Skip to main content

Table 2 Comorbidities and traditional risk factors for cardiovascular diseases

From: Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study

 

TAK (n=20)

CTR (n=16)

P value

SAH or drug treatment

16 (80)

─

─

Dyslipidemia or drug treatment

11 (55)

─

─

Type 2 diabetes mellitus or drug treatment

2 (10)

─

─

Smoker

─

─

─

Total cholesterol (mg/dL)

167.0 (143.5–188.5)

177.0 (148.0–208.0)

0.335

HDL-cholesterol (mg/dL)

60.0 (48.5–74.0)

50.0 (48.0–81.0)

0.899

LDL-cholesterol (mg/dL)

93.0 (78.5–107.0)

109.0 (109.0–120.0)

0.089

Triglycerides (mg/dL)

100.0 (74.5–114.5)

83.0 (53.0–87.0)

0.279

Fasting glucose test (mg/dL)

83.5 (80.25–92.0)

85.0 (81.0–89.0)

0.832

  1. Data are presented as median (25–75%) or percentage (%)
  2. CTR Control group, SAH Systemic arterial hypertension, TAK Takayasu arteritis